Fuxe K - Search Results

1

PEC-60 increases dopamine but not GABA release in the dorsolateral neostriatum of the halothane anaesthetized rat. An in vivo microdialysis study.

Rimondini R, O'Connor WT, Ferré S, Sillard R, Agerberth B, Mutt V, Ungerstedt U, Fuxe K. Rimondini R, et al. Among authors: fuxe k. Neurosci Lett. 1994 Aug 15;177(1-2):53-7. doi: 10.1016/0304-3940(94)90043-4. Neurosci Lett. 1994. PMID: 7824182

2

Studies on the cholinergic and dopaminergic innervation of the neostriatum with the help of intraneostriatal injections of drugs.

Fuxe K, Ungerstedt U. Fuxe K, et al. Pharmacol Ther B. 1976;2(1):29-36. doi: 10.1016/0306-039x(76)90015-5. Pharmacol Ther B. 1976. PMID: 772720 No abstract available.

3

Antiparkinsonian drugs and dopaminergic neostriatal mechanisms: studies in rats with unilateral 6-hydroxydopamine (=6-OH-DA)-induced degeneration of the nigro-neostriatal DA pathway and quantitative recording of rotational behaviour.

Fuxe K, Ungerstedt U. Fuxe K, et al. Pharmacol Ther B. 1976;2(1):41-7. doi: 10.1016/0306-039x(76)90017-9. Pharmacol Ther B. 1976. PMID: 817332 Review. No abstract available.

4

The effect of mepiprazole on central monoamine neurons. Evidence for increased 5-hydroxytryptamine and dopamine receptor activity.

Fuxe K, Agnati LF, Ungerstedt U. Fuxe K, et al. Eur J Pharmacol. 1976 Jan;35(1):93-108. doi: 10.1016/0014-2999(76)90304-6. Eur J Pharmacol. 1976. PMID: 943291

5

The distribution of angiotensin II AT1 receptor subtype mRNA in the rat brain.

Bunnemann B, Iwai N, Metzger R, Fuxe K, Inagami T, Ganten D. Bunnemann B, et al. Among authors: fuxe k. Neurosci Lett. 1992 Aug 17;142(2):155-8. doi: 10.1016/0304-3940(92)90362-b. Neurosci Lett. 1992. PMID: 1280791

6

Evidence for a protective action of the vigilance promoting drug modafinil on the MPTP-induced degeneration of the nigrostriatal dopamine neurons in the black mouse: an immunocytochemical and biochemical analysis.

Fuxe K, Janson AM, Rosén L, Finnman UB, Tanganelli S, Morari M, Goldstein M, Agnati LF. Fuxe K, et al. Exp Brain Res. 1992;88(1):117-30. doi: 10.1007/BF02259133. Exp Brain Res. 1992. PMID: 1347270

7

Intramembrane interactions between neurotensin receptors and dopamine D2 receptors as a major mechanism for the neuroleptic-like action of neurotensin.

Fuxe K, Von Euler G, Agnati LF, Merlo Pich E, O'Connor WT, Tanganelli S, Li XM, Tinner B, Cintra A, Carani C, et al. Fuxe K, et al. Ann N Y Acad Sci. 1992;668:186-204. doi: 10.1111/j.1749-6632.1992.tb27350.x. Ann N Y Acad Sci. 1992. PMID: 1361113 Review.

8

Neuropeptides, excitatory amino acid and adenosine A2 receptors regulate D2 receptors via intramembrane receptor-receptor interactions. Relevance for Parkinson's disease and schizophrenia.

Fuxe K, Agnati LF, von Euler G, Tanganelli S, O'Connor WT, Ferré S, Hedlund P, Zoli M. Fuxe K, et al. Neurochem Int. 1992 Mar;20 Suppl:215S-224S. doi: 10.1016/0197-0186(92)90242-j. Neurochem Int. 1992. PMID: 1365429 Review. No abstract available.

9

Intracerebroventricularly administered pertussis toxin blocks the central vasopressor action of neuropeptide Y(13-36) in the awake unrestrained male rat.

Narváez JA, Aguirre JA, Van der Ploeg I, Fuxe K. Narváez JA, et al. Among authors: fuxe k. Neurosci Lett. 1992 Jun 22;140(2):273-6. doi: 10.1016/0304-3940(92)90119-r. Neurosci Lett. 1992. PMID: 1386917

10

Dopamine denervation leads to an increase in the intramembrane interaction between adenosine A2 and dopamine D2 receptors in the neostriatum.

Ferré S, Fuxe K. Ferré S, et al. Among authors: fuxe k. Brain Res. 1992 Oct 23;594(1):124-30. doi: 10.1016/0006-8993(92)91036-e. Brain Res. 1992. PMID: 1467931

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,336 results

Search Page

Filters